Counter Proliferation Financing
In September 2022 amendments were made to the AML Regulations that now require those affected by them to amend their practice-wide risk assessments, and their policies, controls and procedures. This is to incorporate a contemplation of whether their clients might be involved in the financing of the proliferation of chemical, biological, radiological or nuclear weapons, in breach of international sanctions. This will require some subtle changes to our internal procedures. Watch to find out what we need to do to stay compliant.
PRODUCT INFO
The video session lasts approximately 45 minutes. Once you have bought it, you can use the content as many times as you wish, in as many contexts as you wish.
If you subscribe, you will obtain regular annual updates at a discounted price.
PLEASE NOTE: Prices are quoted exclusive of VAT, which will be added to the invoice.
RETURN & REFUND POLICY
If you are not satisfied with the content of the video, please contact us and we will refund you without quibble.